tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $17.29. This is a potential upside of $17.29 (0%) from yesterday's end of day stock price of $0.
Travere Therapeutics's activity chart (see below) currently has 46 price targets and 34 ratings on display.
Analysts average stock forecasts to be materialized ratio is 28.33% with an average time for these price targets to be met of 208.2 days.
Most recent stock forecast was given by DO KIM from PIPER SANDLER on 06-Nov-2020. First documented stock forecast 13-Feb-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$31
4 years 11 months 28 days ago
(06-Nov-2020)
3/9 (33.33%)
$11.15 (56.17%)
415
Buy
$36
$11.34 (45.99%)
$33
4 years 11 months 29 days ago
(06-Nov-2020)
0/2 (0%)
$13.59 (64.93%)
Buy
$19
5 years 2 months 10 days ago
(24-Aug-2020)
2/3 (66.67%)
$4.6 (31.94%)
217
Buy
$38
$13.34 (54.10%)
$44
5 years 3 months 5 days ago
(29-Jul-2020)
0/2 (0%)
$17.8 (88.12%)
Hold
$19
$-5.66 (-22.95%)
$20
5 years 8 months 9 days ago
(25-Feb-2020)
2/2 (100%)
$4.6 (31.94%)
217
What is RTRX (Travere Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RTRX (Travere Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RTRX (Travere Therapeutics)?
Which analyst is the currently most bullish on RTRX (Travere Therapeutics)?
Which analyst is the currently most reserved on RTRX (Travere Therapeutics)?
